Intsel Chimos - Laboratoire Pharmaceutique
Pharmaceutical-Manufacturing
Website
Company Tagline
Toujours innover et Toujours aller au delà de vos attentes !
Industry Category
Business Keywords
Company Description
Intsel Chimos - Laboratoire Pharmaceutique stands as a prominent entity in pharmaceutical manufacturing, committed to innovation and exceeding expectations. Specializing in the development and distribution of experimental drugs under Named Patient Temporary Authorizations (ATU nominatives) and cohort ATUs, Intsel Chimos also excels in the distribution of hospital generic drugs, particularly prostaglandins. The company secured Orphan Drug status from the EMA (European Medicines Agency) on October 7, 2010, for a molecule indicated in the treatment of glioblastomas.
Located at 162 les bureaux de la Colline, 1 rue ROYALE, SAINT-CLOUD, Ile de France 92210, FR, Intsel Chimos focuses on market access, clinical trials, compassionate access, early access, and exploitant services. Their expertise extends to rare diseases, distribution, and promotion, ensuring comprehensive solutions in the pharmaceutical sector. Since its founding in 1966, Intsel Chimos - Laboratoire Pharmaceutique has built a strong reputation for delivering high-quality pharmaceutical products and services.
Intsel Chimos - Laboratoire Pharmaceutique continues to advance pharmaceutical solutions, driving growth and enhancing patient outcomes. We invite the management team at Intsel Chimos - Laboratoire Pharmaceutique to create a customized and exclusive company showcase and product listing on our platform, highlighting their innovative contributions to the pharmaceutical industry.
Intsel Chimos - Laboratoire Pharmaceutique se distingue comme une entité de premier plan dans la fabrication pharmaceutique, engagée envers l'innovation et le dépassement des attentes. Spécialisé dans le développement et la distribution de médicaments expérimentaux sous ATU nominatives et ATU de cohorte, Intsel Chimos excelle également dans la distribution de médicaments génériques hospitaliers, en particulier les prostaglandines. L'entreprise a obtenu le statut de médicament orphelin de l'EMA (Agence européenne des médicaments) le 7 octobre 2010 pour une molécule indiquée dans le traitement des glioblastomes.
Situé au 162 les bureaux de la Colline, 1 rue ROYALE, SAINT-CLOUD, Ile de France 92210, FR, Intsel Chimos se concentre sur l'accès au marché, les essais cliniques, l'accès compassionnel, l'accès précoce et les services d'exploitant. Son expertise s'étend aux maladies rares, à la distribution et à la promotion, garantissant des solutions complètes dans le secteur pharmaceutique. Depuis sa fondation en 1966, Intsel Chimos - Laboratoire Pharmaceutique s'est forgé une solide réputation pour la fourniture de produits et services pharmaceutiques de haute qualité.
Intsel Chimos - Laboratoire Pharmaceutique continue de faire progresser les solutions pharmaceutiques, stimulant la croissance et améliorant les résultats pour les patients. Nous invitons l'équipe de direction d'Intsel Chimos - Laboratoire Pharmaceutique à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, mettant en évidence leurs contributions innovantes à l'industrie pharmaceutique.
Key Personnel / Employees
Compare Companies Side by Side
Compare Intsel Chimos - Laboratoire Pharmaceutique with 3 companies in Pharmaceutical-Manufacturing
| Comparison Field |
Intsel Chimos - Laboratoi...Main Company |
Clinerion LtdView Profile |
LoonView Profile |
ACTG-CROView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2008 | 2022 | 2019 |
|
Company Size
|
— | 11-50 | 2-10 | 2-10 |
|
City
|
SAINT-CLOUD, Ile de France | Basel, Basel-Town | Ottawa, Ontario | Tunis, Les Berges du Lac I |
|
Country
|
Switzerland | Canada | ||
|
Skills & Keywords
Comparing with main company
|
13 Total Skills
Pharmaceutical Manufacturing
Experimental Drugs
Generic Drugs
Prostaglandins
Market Access
Clinical Trials
Rare Diseases
Compassionate Access
Early Access
Exploitant Services
Rare disease
Distribution
Promotion
|
11 Total
1 Common
10 Unique
Match
8%
Common Skills:
Rare Diseases
Unique Skills:
artificial intelligence
machine learning
Orphan Drugs
Patient Identification
Patient Search
Precision Medicine
+4
|
37 Total
37 Unique
Unique Skills:
AI
Biopharmaceutical Commercializations De-Risking
Clinical AI
Clinical Development
Clinical Discovery
Clinical Intelligence
+31
|
30 Total
30 Unique
Unique Skills:
Africa
Anti-counterfeiting Technology Solution
Business Development
Business Expansion
Clinical Data Management
Clinical Monitoring
+24
|
4
Total Companies2008
Oldest Founded2
Countries89
Unique SkillsSimilar Companies
Other organizations in the same industry
Keymen İlaç
Pharmaceutical-ManufacturingAlagöz Holding, Türkiye’nin aşı tedariğini 1973’ten günümüze iştiraki Keymen İlaç güvencesi ile gerç...
Alternative Company Names
This company is also known as